Skip to main content
Clinical Trials/NCT02003170
NCT02003170
Completed
N/A

Etiology and Early Diagnosis of Neurodevelopmental Disorders

University of Arkansas1 site in 1 country576 target enrollmentMay 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Neurodevelopmental Disorders
Sponsor
University of Arkansas
Enrollment
576
Locations
1
Primary Endpoint
Medical abnormalities associated with specific neurodevelopmental disorders
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.

Detailed Description

Although neurodevelopmental disorders are very prevalent (for example Autism affects 1 out of every 88 children and dyslexia affects up to 15% of the population), the etiology of such disorders is not known. The purpose of this investigation is to identify common etiologies of neurodevelopmental disorders (i.e., speech delay, global developmental delay, autism) and determine if it is possible to find early indicators of the diagnosis and foster the potential for a better prognosis of these disorders. At this time the investigators examine patients with neurodevelopment disorders with various medical investigations, but the results of these investigations are not systematically evaluated. One of the goals of this research is to systematically examine this information in order to identify patterns of test abnormalities that have not been previously described. Another goal of this research is to identify the common etiologies typically identified by the medical evaluation, so we can further refine our approach. In addition, the investigators now have the ability to evaluate biological samples for biomarkers that have potential to be diagnostically useful.

Registry
clinicaltrials.gov
Start Date
May 2012
End Date
June 6, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Neurodevelopmental delays
  • Clinical visit at an Arkansas Children's Hospital Outpatient clinic

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Medical abnormalities associated with specific neurodevelopmental disorders

Time Frame: up to 7 years

It is unknown if a specific set of biological abnormalities contribute to the formation of many types of neurodevelopmental disorders. The study is intended to identify the relationship between biological abnormalities and neurodevelopmental disorders

Secondary Outcomes

  • Treatments associated with neurodevelopmental disorders(up to 7 years)
  • Biomarkers associated with neurodevelopmental disorders(up to 7 years)

Study Sites (1)

Loading locations...

Similar Trials